Lactulose as a novel template for anticancer drug development targeting galectins
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lactulose as a novel template for anticancer drug development targeting galectins
Authors
Keywords
-
Journal
Chemical Biology & Drug Design
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-06-11
DOI
10.1111/cbdd.13348
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacological inhibition of galectin-1 by lactulose alleviates weight gain in diet-induced obese rats
- (2016) Rajib Mukherjee et al. LIFE SCIENCES
- Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors
- (2016) Tung-Ju Hsieh et al. Scientific Reports
- Inhibition of Prostate Cancer Bone Metastasis by Synthetic TF Antigen Mimic/Galectin-3 Inhibitor Lactulose-l-Leucine
- (2015) Olga V. Glinskii et al. NEOPLASIA
- Unraveling galectin-1 as a novel therapeutic target for cancer
- (2013) Lucile Astorgues-Xerri et al. CANCER TREATMENT REVIEWS
- Investigation into the Feasibility of Thioditaloside as a Novel Scaffold for Galectin-3-Specific Inhibitors
- (2013) Khuchtumur Bum-Erdene et al. CHEMBIOCHEM
- Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma
- (2013) María L Bacigalupo WORLD JOURNAL OF GASTROENTEROLOGY
- Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
- (2012) Koichi Ito et al. CANCER AND METASTASIS REVIEWS
- The sweet and bitter sides of galectins in melanoma progression
- (2012) Russell R. Braeuer et al. Pigment Cell & Melanoma Research
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy
- (2011) S. Shukla et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Taloside Inhibitors of Galectin-1 and Galectin-3
- (2011) Patrick M. Collins et al. Chemical Biology & Drug Design
- Galectin-1 and immunotherapy for brain cancer
- (2011) Tina Verschuere et al. Expert Review of Neurotherapeutics
- The role of galectins in colorectal cancer progression
- (2011) Hannah Barrow et al. INTERNATIONAL JOURNAL OF CANCER
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model
- (2010) Kimberley A. Stannard et al. CANCER LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started